![Mark Timney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Timney
Chief Executive Officer at
Attralus, Inc.
Profile
Currently, Mark Timney is Chairman at Blade Therapeutics, Inc. and Chief Executive Officer & Director at The Medicines Co. Mr. Timney is also on the board of Biotechnology Innovation Organization, Pharmaceutical Research & Manufacturers of America and Sarissa Capital Acquisition Corp. In his past career Mr. Timney held the position of President & Chief Executive Officer for Purdue Pharma LP, President-Global Primary Care at Merck & Co., Inc. and Chief Executive Officer & Director at The Medicines Co. Mark Timney received an undergraduate degree from the University of Northumbria.
Mark Timney active positions
| Companies | Position | Start |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Board Member | - |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Chairman | 2020-07-31 |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Chief Executive Officer | 2021-05-09 |
Anfield Road LLC | Chief Executive Officer | 2016-12-31 |
Former positions of Mark Timney
| Companies | Position | End |
|---|---|---|
| SARISSA CAPITAL ACQUISITION CORP. | Director/Board Member | 2023-04-12 |
| THE MEDICINES COMPANY | Chief Executive Officer | 2019-12-31 |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Chief Executive Officer | 2017-06-22 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2014-06-30 |
Education of Mark Timney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
University of Northumbria
 University of Northumbria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Health Technology |
Sarissa Capital Acquisition Corp.
 Sarissa Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Anfield Road LLC |
- Stock Market
- Insiders
- Mark Timney
